Search
  1. Home
  2. East Africa
  3. Kenya
  • News

GSK to boost HIV/AIDS healthcare rollout

    JOHANNESBURG

    Multinational drug manufacturer GlaxoSmithKline (GSK) has announced a multimillion-dollar programme to improve HIV/AIDS treatment at 60 facilities in Kenya.

    The firm's CEO, Jean Pierre Garnier, said the US $1.8 million initiative aimed to advance healthcare delivery and strengthen access to support services in the country's most deeply affected communities.

    In a statement Garnier said, "Together we will bring hope and improved treatment to thousands of people affected by the pandemic in Kenya."

    He noted that the three-year project, funded by his firm's 'Positive Action' community support programme, had the potential to be rolled out in other African countries as well.

    According to the National Empowerment Network of People Living with HIV/AIDS in Kenya, there are an estimated 2.2 million people living with the HI virus.

    This article was produced by IRIN News while it was part of the United Nations Office for the Coordination of Humanitarian Affairs. Please send queries on copyright or liability to the UN. For more information: https://shop.un.org/rights-permissions

    Share this article

    Our ability to deliver compelling, field-based reporting on humanitarian crises rests on a few key principles: deep expertise, an unwavering commitment to amplifying affected voices, and a belief in the power of independent journalism to drive real change.

    We need your help to sustain and expand our work. Your donation will support our unique approach to journalism, helping fund everything from field-based investigations to the innovative storytelling that ensures marginalised voices are heard.

    Please consider joining our membership programme. Together, we can continue to make a meaningful impact on how the world responds to crises.

    Become a member of The New Humanitarian

    Support our journalism and become more involved in our community. Help us deliver informative, accessible, independent journalism that you can trust and provides accountability to the millions of people affected by crises worldwide.

    Join